Workflow
GTHT(02611)
icon
Search documents
国泰海通(02611) - 翌日披露报表
2025-05-08 09:00
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 確認 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 A | | 於香港聯交所上市 | 否 | | | 證券代號 (如上市) | | 說明 | A股於上海證券交易所上市(證券代號: 601211) | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | 佔有關事件前的現有已發 行股份(不包括庫存股 份)數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2025年4月30日 | 14,059,238,879 | | 64,709,969 | | 14,123,948,848 | | 1). 購回股份 ( ...
国泰海通(02611) - 年度股东大会通告
2025-05-08 08:42
香港交易及結算所有限公司及香港聯合交易所有限公司對本通告的內容概不負責,對其準確性或完整性亦 不發表任何聲明,並明確表示,概不對因本通告全部或任何部份內容而產生或因倚賴該等內容而引致的任 何損失承擔任何責任。 國泰海通證券股份有限公司 Guotai Haitong Securities Co., Ltd. (於中華人民共和國註冊成立的股份有限公司) (股份代號:02611) 國泰海通證券股份有限公司 年度股東大會通告 茲通告國泰海通證券股份有限公司(「本公司」)謹訂於2025年5月29日(星期四) 下午一時三十分假座中國上海市黃浦區中山南路888號國泰海通外灘金融廣場C棟616 會議室舉行年度股東大會(「年度股東大會」),藉以審議並酌情通過以下決議案。除非 文義另有所指,本通告所用詞彙與本公司日期為2025年5月9日的通函(「通函」)所定義 者具有相同涵義。 普通決議案 – 1 – 1. 審議及批准2024年董事會工作報告。 2. 審議及批准2024年監事會工作報告。 3. 審議及批准本公司2024年度利潤分配方案。 4. 審議及批准續聘外部審計師的議案。 5. 審議及批准本公司2024年年度報告。 6. 審 ...
国泰海通(02611) - 2024年董事会工作报告;2024年监事会工作报告;2024年度利润分配...
2025-05-08 08:38
此乃要件 請即處理 閣下如對本通函的任何方面或應採取的行動有任何疑問,應諮詢 閣下的股票經紀或其他註冊證券交易商、銀行經理、律師、專業會計 師或其他專業顧問。 閣下如已將名下全部國泰海通證券股份有限公司的股份售出或轉讓,應立即將本通函及代表委任表格以及(如適用)2024年年度報告交 予買方或承讓人,或送交經手買賣或轉讓的銀行、持牌證券商或其他代理商,以便轉交買方或承讓人。 香港交易及結算所有限公司及香港聯合交易所有限公司對本通函的內容概不負責,對其準確性或完整性亦不發表任何聲明,並明確表 示,概不就因本通函全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 國泰海通證券股份有限公司 Guotai Haitong Securities Co., Ltd. (9) 撤 銷 公 司 監 事 會; (10) 增 發 A 股及╱或 H 股 股 份 的 一 般 性 授 權; (11) 發 行 境 內 外 債 務 融 資 工 具 的 一 般 性 授 權; (於中華人民共和國註冊成立的股份有限公司) (股份代號:02611) (1)2024 年 董 事 會 工 作 報 告; (2)2024 年 監 事 會 ...
国泰海通(02611) - 变更公司网站
2025-05-08 08:32
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 國泰海通證券股份有限公司 Guotai Haitong Securities Co., Ltd. (於中華人民共和國註冊成立的股份有限公司) (股份代號:02611) 變更公司網站 國泰海通證券股份有限公司(「本公司」)董事會(「董事會」)僅此公佈,自2025年5 月8日起,本公司網站已由「 www.gtja.com 」變更為「 www.gtht.com 」。本公司提交 以供香港聯合交易所有限公司網站發佈的所有公告、通告及其他文件,亦將於本 公司新網站發佈。 承董事會命 國泰海通證券股份有限公司 朱健 董事長 截至本公告日期,本公司的執行董事為朱健先生、李俊傑先生以及聶小剛先生; 本公司的非執行董事為周杰先生、管蔚女士、鐘茂軍先生、陳航標先生、呂春芳 女士、哈爾曼女士、孫明輝先生以及陳一江先生;及本公司的獨立非執行董事為 李仁傑先生、王國剛先生、浦永灝先生、毛付根先生、陳方若先生以及江憲先生。 中國上海 ...
8日对二甲苯上涨2.14%,最新持仓变化
Xin Lang Qi Huo· 2025-05-08 08:23
新浪期货 根据交易所数据,截至5月08日收盘主力合约对二甲苯2509,涨跌+2.14%,成交量29.36万手,持仓数据显示前20席位呈现 净空,差额头寸为5923手。 对二甲苯期货全合约总计成交36.98万手,比上一日新增5.48万手。全合约前20席位多头持仓16.97万手,比上一日增加2.26万手。 全合约前20席位空头持仓17.51万手,比上一日增加1.50万手。 根据合并数据显示,多头前三席位为国泰君安,总持仓22347、中信期货,总持仓14133、东证期货,总持仓11603;空头前三席位 为国泰君安,总持仓32487、华泰期货,总持仓15927、东证期货,总持仓12920; 主力合约前20席位中,多头增仓前三名分别是:华泰期货、持仓4331、增仓1944,乾坤期货、持仓3353、增仓1647,东证期货、 持仓6155、增仓1295;多头减仓前三名分别是:浙商期货、持仓4680、减仓-228,中信期货、持仓12787、减仓-152,广发期货、 持仓1977、减仓-134; 主力合约前20席位中,空头增仓前三名分别是:银河期货、持仓5196、增仓2003,徽商期货、持仓1990、增仓1071,恒力期货、 ...
国泰海通:具身智能驱动人形机器人商业化落地 算法突破等成行业上涨催化剂
智通财经网· 2025-05-08 07:56
Group 1 - The core viewpoint is that embodied intelligence is the key to the commercialization of humanoid robots, with a market space exceeding one trillion yuan, and the intelligent level of humanoid robots in China is expected to evolve significantly by 2045 [1] - Humanoid robots possess human-like perception, body structure, and movement, making them highly adaptable to human society, with potential applications in manufacturing, social services, and hazardous operations [1] - The market scale for humanoid robots is currently below ten billion yuan, but as intelligent levels progress towards embodied intelligence, the market is expected to expand significantly [1] Group 2 - Multi-modal large models and reinforcement learning are enhancing operational control performance, with significant advancements in communication and computing power to support real-time control [2] - Major companies like NVIDIA and Tesla are integrating multi-modal perception to improve robot interaction and decision-making accuracy, while the development of embodied reasoning models is expected to enhance performance in complex environments [2] - The adoption of pure visual solutions and advanced sensors is anticipated to lower hardware costs and improve perception sensitivity, with EtherCAT emerging as a mainstream communication protocol due to its high real-time performance [2]
券商分红大比拼!2024年“账单”来了,榜首换“新人”
券商中国· 2025-05-08 01:01
Group 1 - The core viewpoint of the article highlights that listed securities firms are increasingly committed to shareholder returns, with a total of 387.4 billion yuan planned for year-end dividends in 2024, despite some firms opting out due to negative distributable profits [1][2][7] - Among the 42 listed securities firms, only Tianfeng Securities and Pacific Securities will not distribute dividends due to negative distributable profits, while 17 firms have a cash dividend ratio exceeding 40%, which is an increase from 2023 [1][2][8] - The total cash dividends for 2024 are projected to be higher than in 2023, with a total of 536.87 billion yuan distributed in mid-year and third-quarter dividends, leading to an overall increase of 128 billion yuan compared to the previous year [2][8] Group 2 - The top cash dividend amounts for 2024 are led by Guotai Junan with 49.23 billion yuan, followed by CITIC Securities with 41.50 billion yuan, and other firms like Guoxin Securities and Huatai Securities also contributing significant amounts [2][3] - A total of 27 firms plan to distribute between 100 million to 1 billion yuan, while 6 firms will distribute over 3 billion yuan, indicating a robust dividend distribution strategy among the majority of firms [2][3] - The cash dividend ratio for several firms remains high, with notable mentions including Guolian Minsheng at 80%, Hongta Securities at 64%, and Southwest Securities at 62%, despite some firms experiencing declines in net profit [3][6] Group 3 - The trend of increasing dividend frequency is evident, with 33 firms planning to distribute dividends two or more times in 2024, compared to only one firm in 2023 [8][9] - A total of 29 firms have maintained a cash dividend ratio of 30% or more over the past three years, showcasing a commitment to consistent shareholder returns [8][9] - The average dividend yield among 40 listed securities firms is 1.63%, with only a few firms exceeding a 3% yield, indicating that while dividends are increasing, the sector may not yet be classified as a high-dividend sector [10] Group 4 - Companies are focusing on balancing strategic development, performance growth, and shareholder returns, with management emphasizing the importance of investor relations and consistent cash dividends as part of their market value management strategies [11][10] - Specific measures to enhance investor confidence include encouraging long-term shareholding by major shareholders, implementing share buybacks, and utilizing employee stock ownership plans to boost company value [11]
国泰海通:A股市场逐渐企稳回升 建议后续基金适度偏向成长配置
智通财经网· 2025-05-07 22:57
Group 1 - The A-share market is gradually stabilizing and recovering after the impact of "reciprocal tariffs," with a slight decline for the month. It is suggested that future fund allocations maintain a balanced style while moderately leaning towards growth, emphasizing the importance of fund managers' stock selection and risk control capabilities [1][2] - In April, the manufacturing PMI was 49.0%, a decrease of 1.5 percentage points from the previous month, influenced by the drastic changes in the external environment due to trade friction. The strategy team believes that after the shock, investors' understanding of the economic situation has improved, which is crucial for the stock market's recovery [2] - The focus of Sino-US competition extends beyond economic trade to technological and productivity advantages. In the medium to long term, emerging technology remains a key theme, and the financial cycle is expected to be a dark horse under the influence of declining risk-free interest rates and new capital inflows [2] Group 2 - Global central bank gold purchasing behavior is expected to be long-term and sustained, reflecting changes in the trust foundation of the global monetary system. The rise of trade protectionism and the restructuring of the global economy will increase economic differentiation, supporting residents' demand for gold [3] - The fundamental impact of the US dollar on gold pricing has weakened but still holds some influence. If the US economy weakens, the support for gold prices will strengthen. This gold bull market is characterized by different driving factors and pricing frameworks, suggesting a potentially long cycle [3] - From a long-term investment and risk-hedging perspective, it is recommended to allocate to gold ETFs [3]
微芯生物:5月6日进行路演,宏利基金、国泰海通等多家机构参与
Sou Hu Cai Jing· 2025-05-07 13:20
Core Viewpoint - Micron Biologics (688321) is actively advancing its clinical pipeline, focusing on unmet medical needs in diabetes and liver diseases, while also exploring new drug forms and potential partnerships for drug development [1][2][3][4][5]. Group 1: Clinical Developments - The company has conducted market research indicating a significant overlap between patients with early-stage diabetes and those with metabolic fatty liver disease (MFLD/MSH), with about 55% of type 2 diabetes patients also having MFLD/MSH [1]. - The drug Siglecatin (Dulaglutide) has been approved for type 2 diabetes and included in medical insurance, showing multiple benefits such as liver fat reduction and improved fibrosis in Phase II clinical trials [1]. - The clinical trial for Sidabenamide in combination with other drugs for advanced colorectal cancer has successfully enrolled 200 out of 430 planned patients, with the trial progressing as scheduled [2]. Group 2: Pipeline Progress - The company is advancing several projects in Phase I and II clinical stages, including CS23546 (PD-L1 small molecule inhibitor) and CS231295 (brain-penetrant aurora B selective inhibitor), with plans for overseas clinical submissions [3]. - The company is preparing for potential licensing opportunities for early-stage molecules, actively engaging with external partners to enhance its drug development pipeline [4]. Group 3: Financial Performance - In Q1 2025, the company reported a main revenue of 162 million yuan, a year-on-year increase of 24.24%, while the net profit attributable to shareholders was -19.15 million yuan, a decrease of 4.64% [5]. - The company has a debt ratio of 52.84% and a gross profit margin of 85.64%, indicating a strong financial position despite recent losses [5]. - Recent institutional ratings show a positive outlook, with two firms issuing buy ratings within the last 90 days [5][6].
破发股翱捷科技跌6.64% 上市超募42亿元国泰海通保荐
Zhong Guo Jing Ji Wang· 2025-05-07 08:49
Core Viewpoint - Aojie Technology (688220.SH) is currently facing a decline in stock price, with a drop of 6.64% to 89.48 yuan, indicating a state of being below its initial public offering (IPO) price [1] Financial Performance - In 2024, Aojie Technology reported a revenue of 3.39 billion yuan, representing a year-on-year increase of 30.23% compared to 2.14 billion yuan in 2022 [2][3] - The net profit attributable to shareholders was -693 million yuan in 2024, worsening from -505 million yuan in the previous year [2][3] - The company's net profit excluding non-recurring gains and losses was -707 million yuan in 2024, compared to -658 million yuan in 2023 [2][3] - The net cash flow from operating activities was -404 million yuan in 2024, an improvement from -678 million yuan in 2023 [2][3] IPO and Fundraising - Aojie Technology went public on January 14, 2022, with an IPO price of 164.54 yuan per share, raising a total of 6.883 billion yuan, which was 4.166 billion yuan more than initially planned [1] - The funds raised are intended for projects including new communication chip design and high-precision navigation solutions [1]